Class II (Ia) molecules are polymorphic integral membrane proteins that, in association with processed antigen, comprise the ligand complex bound by antigen receptors (TCR) on CD4+ T lymphocytes. The association of this ligand with the TCR on T helper lymphocytes initiates the activation program that is a requisite event for the promotion ofboth humoral and cell-mediated immune responses. During the past several years much has been learned about the sequences of class II molecules, peptide antigens, and TCRs . Hypothetical models of the class II three-dimensional molecular structure have also been proposed, based on the solution to the class I crystal structure (1). Although direct binding analyses indicate that a TCR ligand is formed when class II molecules bind to processed antigen (2, 3), only limited information is available concerning the molecular interactions that occur when a class II molecule associates with a peptide antigen and a TCR.
residues in the 01 domain that determine either the loss or the gain of epitopes recognized by these alloreactive TCRs. Our results demonstrate that both antibody and TCR binding sites can be comprised of the same 0 chain polymorphic residues.
However, the majority ofthe TCR binding sites identified with this panel ofalloreactive T cell hybridomas map to polymorphic residues that are predicted to be located at the bottom of the putative antigen binding site on the class II molecule.
Materials and Methods
Cell Lines. The panel of wild-type or mutant class II-bearing cloned cell lines was prepared by transfecting into MUM B lymphoma cells, plasmids containing the wild-type Ak or mutant Ap (designated-AS') genes, the neomycin resistance gene pRSVneo, and in certain cases, with the wild-type Ak gene . A detailed description of the methods used to construct the A,3 genes and to transfect the genes into MUM cells is given elsewhere (9) . Cloned lines bearing class II molecules were selected by quantitative immunofluorescence for comparable levels of class II antigen expression . Nomenclature : As* and Aa transfected M12 .C3 cells are designated TN, with N indicating the position(s) or polymorphic region(s) substituted in the As" /31 domain with d-allele residues . Cells expressing A k* Ad molecules are designated TN-Ad and cells expressing wild-type A« polypeptide associated with an A~poly-peptide containing d allele residues throughout the (31 domain are designated TApk Aa . The transfected cells were cultured in RPMI 1640 medium (Gibco Laboratories, Grand Island, NY), 1 MM L-glutamine, 0 .1 mM 2-ME, 10 mM Hepes, and 600 ftg/ml G418 .
T CellAssays . T hybridomas 59 .16, 22 .1, and 98 .11 were produced by fusing BW5147 cells with lymph node cells from DBA/2 mice that had been primed in vivo with TAk cells (M12 .C3 cells expressing wild-type A k and Ak genes) . T hybridoma DG11 is a CBA/J anti-BALB/c origin and hybridoma DIG10 is a C57BL/6 anti-BALB/c origin . Both hybridomas are Ad-reactive (10) . IC4 is an Ad-autoreactive T cell hybrid (10) . The Ad-reactive T hybrids were generously provided by Dr. Robert Chesnut (National Jewish Hospital, Denver, CO) .
To assay for T hybridoma activity, 10 5 T hybridoma cells were cocultured with varying numbers of wild-type or mutant class II-bearing MUM cells or with mock-transfected (TNEO) cells . After 24 h of culture, supernatants were collected and assayed for IL-2 content in a secondary culture by using HT-2 cells as previously described (11) . HT-2 cells 
Results
The Ak and Ad class II proteins differ significantly in both their allospecific serologic epitopes and TCR binding sites. To identify which of the 14 (31 domain positions that differ between the k and d alleles are responsible for determining the allospecificities, we have produced a panel of cloned cell lines, each of which expresses a mutant Ak (A k*) polypeptide (containing one or more d allele residues in the /31 domain) associated with either a wild-type Akn polypeptide or a wild-type Ad polypeptide (see Fig . 1 for a description of the Ak* mutants) .
Loss of k Allele Specicities.
The mutant class II-bearing cells were tested for the capacity to stimulate IL-2 secretion from three different Ak-reactive (A d -nonreactive) T cell hybridomas . Representative experiments illustrating the effects of mutations in different regions of the (31 domain are shown in Fig . 2 , while the complete set of variants tested is summarized in Table I Table I ) . In contrast, the third T hybridoma, 98 .11, is activated equally well by cells expressing either wild-type AO Aa or AO Ad molecules (Fig . 2 C) . None of the T hybridomas are activated by the Ia", mock-transfected MUM cells (TNeo) or by cells expressing an la molecule consisting of a AO* polypeptide containing d allele sequence throughout the entire (31 domain associated with a wild-type A', polypeptide (TAak Adl) . These results indicate that the antigen receptors on the T hybridomas 22 .1 and 59 .16 recognize some combination of k allele polymorphic residues in both the /31 domain and in the A« polypeptide. In contrast, the antigen receptors on the T hybridoma 98 .11 recognize k allele polymorphic residues in the /31 domain but do not discriminate A« from Aa polymorphic residues .
When these three Ak-reactive T cell hybridomas were assayed for their response to the mutant class II molecules, the response of the T hybridomas 22_1 and 59 .16 to the class II mutant that contains d allele residues in the entire COOH-terminal half of the (31 domain (TBCD) was greater than the response to wild-type AO Aa molecules. Since TBCD cells do not express higher levels of class II molecules than wild-type TAO Aa cells (9) , the observed response likely results from the TCRs on these two T hybridomas binding with higher affinity to the class II ligand complex on TBCD cells than on T.AO Aa cells (Fig . 2 , A and B; Table I ) . Both T hybridomas also reacted to AO* mutants containing single d allele residues at either position 28 or 40 (T28, T40) . These results indirectly suggest that the antigen receptors on both T cell clones recognize /3 chain polymorphic residues in region "A" (residues 9-17). We cannot assess directly if the TA AO* Aa molecule will stimulate these two T hybridomas because the mutant AO* polypeptide containing d allele residues in region "A" cannot be expressed in association with the Ak molecule (12) . However, we were able to map the epitope recognized by these two T hybridomas by assaying cells expressing the wild-type A k polypeptide with an AO* polypeptide containing a single d allele substitution at either position 9, 12, 13, 14, or 17 . As shown in Fig.  2 , A and B, and Table I , T hybridoma 59 .16 responds to mutants T.9 and T.17 but not to mutants T12, T13, or T14, while T hybridoma 22 .1 is not stimulated by any of these five single residue mutants. Together these analyses map the epitopes recognized by these T cell receptors to an overlapping set of polymorphic residues in region "A" of the (31 domain .
In contrast, T hybridoma 98 .11, which fails to discriminate Ac', from Aa polypeptides, responds to the cell line expressing the AO* A« molecule containing d allele residues in region "A" (TA-A«) (Fig . 2 C) . When the /3 chain mutants with d substitutions in either region "B", "C", "D", or combinations of these polymorphic regions were assayed, none stimulated the 98 .11 T cells. Thus, although the epitopes recognized by T hybridomas 59 .16 and 22 .1 map to a limited number of k allele polymorphic residues (12, 13, 14 or 9, 12, 13, 14, 17, respectively), the T hybridoma 98 .11 appears to recognize a complex epitope determined by k allele polymorphic residues in regions "B", "C", and "D".
Gain of spatially distant residues. Such conformational alterations are difficult to detect and could result in the misidentification of the polymorphic residues that comprise the TCR contact points . An alternative to measuring the loss of allospecificities in the panel of mutant AQ* stimulator cells is to assay for the gain of new d allospecificities after the introduction of a limited number of d allele residues into the Ap polypeptide sequence. It is more likely that the gain of an Ad-specific epitope will be due directly to the structural alterations introduced by the d allele polymorphic residues.
When three different Ad reactive T hybridomas were tested with the panel of mutants, each of the T cells was activated by the stimulator cells expressing wild-type Ad d and an Ak* molecule containing d allele residues throughout the 01 domain (TAak Add) ( Fig. 3 ; Table I ). Cells expressing Neo, wild-type AO Act, or wild-type Aa A« molecules failed to stimulate these T cells. These results suggest that the antigen receptors on these T hybridomas recognize d allele polymorphic residues in the /31 domain. Since the Ag polypeptide fails to associate with the Aa polypeptide (7), possible contributions of the a polymorphic residues to the T cell epitopes were assessed from mutant A0* polypeptides that can associate with Aa.
When the three T hybridomas were assayed with the /3 chain mutants, each exhibited a distinct reactivity pattern . As shown in Fig. 3 A, clone DG11 is stimulated by class II molecules comprised of a wild-type A« (or Ad,,) polypeptide and an Aa* polypeptide containing three d allele residues at positions 65-67 (T65-67 or T65-67-Aa). As summarized in Table I, in previous experiments as being directly responsible for determining the loss of Ak specific serologic epitopes and the gain of Ad-specific serologic epitopes (9) . Thus, the DG11 antigen receptor recognizes an epitope composed of, in part, the same polymorphic residues that comprise the immunodominant R chain serologic epitope. In addition, both the antibodies that react with the epitope comprised of residues 65-67 and the DGll TCR recognize the T65-67, TB, and TBCD AO* polypeptides associated with either the Akk or the Ad d polypeptide (Table I ) . These results demonstrate that neither these serologic epitopes nor the DG11 TCR epitope is affected by the substitution of k or d a chain polymorphic residues . The hybridoma IC4 is reactive to Ia molecules composed of a wild-type Add poly_ peptide and a Ak* polypeptide containing d allele residues in both regions "A" and "D" (TAD-Ad d, TACD-Aa) ( Fig. 3, B ; Table I ) . Since neither TA AO* A« molecules nor TD Aa* A« molecules activate IC4, the IC4 antigen receptor appears to recognize a complex epitope composed of polymorphic residues in these two regions that are widely separated in the primary sequence . As will be discussed later, these polymorphic residues are also predicted to be widely separated in the molecule's threedimensional structure (1).
Although the panel of class II mutants has enabled us to map the a chain location of the epitopes recognized by receptors on five of the six T hybridomas, we have been unsuccessful at identifying any mutant Ak* molecule, other than TAsk Ad d that will stimulate the T hybridoma DlG10 (Table I ) . The antigen receptor on this T hybridoma may recognize a complex epitope containing a large number of d allele polymorphic residues in the (31 domain (as expressed by T.A~k Ad or combinations of d allele residues not represented in our panel of /3 chain mutants. For example, an epitope composed of d residues at both positions 40 and 63 would not be identified in this analysis . A serologic epitope containing these two residues has been identified previously in the analysis of the Aa-reactive mAb Y-212 (9).
Discussion
Brown et al . (1) have recently proposed a hypothetical model of the three-dimensional conformation of the class II a1M domain based on the crystal structure of the HLA A2 molecule . In this model, the polymorphic positions that we have identified as contributing to the TCR binding sites are predicted to be located in distinct areas of the class II molecule . The polymorphic residues in region "B", which are recognized by the Ad-reactive T hybridoma, DG11, as well as by several Ad-or A'-reactive mAbs, are predicted to be located in a turn between two a-helices that comprise two sides of the putative antigen binding site . The side chains of these polymorphic residues should be exposed to the aqueous environment on the exterior of the class II molecule . Secondary structure predications suggest that region "D" is located in a turn at the end of an a-helix (comprised, in part, of "C" region residues) that forms one side of the putative antigen binding site . Thus, the 98 .11 TCR epitope, which maps to regions B, C, and D, is predicted to be located on one side wall of the putative antigen binding site. In contrast, region "A", which has been identified as comprising part of the TCR epitope for three of the six T hybridomas assayed, is predicted to be located in a (3-pleated sheet that forms the bottom of the putative antigen binding site . Together these results indicate that the TCR epitopes map to a number of residues that may be located in distinct regions in the 01 domain .
Results from a number ofdifferent studies have indicated that TCRs bind to regions on class II molecules that are distinct from the regions bound by mAbs (13) (14) (15) . The results presented here demonstrate that at least four of the six T hybridomas tested recognize regions on the ß chain that are distinct from the serologically immunodominant region that maps to residues 63-67 . However, the antigen receptor on one T hybridoma, DGII, appears to recognize the polymorphic residues 65-67 . Although we cannot determine from these analyses if the same nonpolymorphic residues comprise both TCR and serologic epitopes, it is apparent that both types of molecules are capable of binding to similar regions on the class II molecule .
It has been suggested previously that, unlike serologic epitopes, the ligand recognized by most Th cells requires contributions of polymorphic residues in both the a and ß chains (8) . Results obtained in this study are consistent with this observation in that four of the six alloreactive T hybridomas tested recognize epitopes determined by polymorphic residues in both polypeptides . Antigen-reactive TCR combining sites may interact with residues from both polypeptides because it is these residues in the a1ß1 domain that comprise or are adjacent to the putative antigen binding site . It is unlikely that the location ofserologic epitopes on class II molecules is similarly constrained. It is interesting to note that the DG11 TCR binding site, which is comprised of the same ßl domain polymorphic residues shown previously to comprise part of the immunodominant serologic epitope, is similar to the ß chain-specific serologic epitopes in that the TCR reacts with class II molecules consisting of either Add or Akk polypeptides . Although the similarity in the Ab and TCR epitopes may be fortuitous, it may reflect a fundamental difference between the nature of some allospecific T cell determinants and determinants that are comprised of processed antigen and self class 11 molecules .
The data presented in this report clearly identify the polymorphic residues responsible for the activation of several Ak-and Ad-specific T hybridomas . These residues may be the contact points that mediate TCR binding. However, it has been hypothesized that the ligand recognized by alloreactive TCRs is a composite of foreign class II residues and residues ofa processed peptide located in the class II antigen binding site (16, 17) . If this hypothesis is correct, we may have identified residues that are actually contact points for a processed polypeptide, which may be the principal ligand bound by the alloreactive T cell hybridoma receptors. However, both types ofligands could be represented in this analysis. For example, TCRs that map to region "A" may recognize ligands that are composed of some combination of residues from a processed peptide and the class II molecule, while TCRs that map to polymorphic residues that also comprise the serologically immunodominant site (region "B") may recognize ligands made up of only class II residues . Direct experimental evidence for either type of allo-reactive T cell ligand is lacking. The panel of Ia mutants and T hybridomas described in this report provides a defined model system with which to experimentally evaluate this problem.
Summary
In an effort to characterize the ligand that is bound by T helper lymphocyte antigen receptors, we have begun to identify class II polymorphic residues that comprise part of the allospecific TCR binding sites. Site-directed mutagenesis was used to construct mutant Aá (Aß*) genes that encode polypeptides into which single or multiple residues of the Ad polypeptide have been substituted in the 01 domain . A panel of cloned cell lines expressing the mutant AO* A« or AO* A« molecules was analyzed for the ability to stimulate Ak or Ad alloreactive T cell hybridomas. Substitution of d for k residues at specific positions in the 01 domain resulted not only in the loss of epitopes recognized by Ak-reactive T cells but, more importantly, in the gain of epitopes recognized by Ad-reactive T cells. Some of the polymorphic residues identified as contributing to the T cell epitopes are the same residues that contribute to the serologically immunodominant epitope . Other T cell epitopes map to positions predicted to be located either in an cz-helix forming one side, or in a ,6-pleated sheet forming the bottom of the putative antigen binding site. Thus, unlike serologic epitopes, TCR epitopes can be determined by A0 polymorphic residues in many different regions of the /31 domain and frequently depend upon contributions of A« polymorphic residues.
